This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine’s Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
Corinthia mindset ‘quite unique’ – Bernold Schroeder
He joins Corinthia Group as a consultant after three decades of hospitality leadership with Kempinski, Jin Jiang, Pan Pacific and ...
Valletta Credit Finance Corporation launched during impressive ‘history of money’ themed event
The VCFC is a modern payments institution.
‘Evans Building project will be a source of pride for residents’ – Simon De Cesare
Eden Leisure Group CEO says he is extremely happy with the recent Appeals Court ruling.
HSBC Malta CEO: ‘Business as usual’ as bank prepares for transition to CrediaBank
He emphasised that continuity of people, relationships and expertise will remain at the heart of the bank’s transition.
